1. Wellcome-BCG, Unlocking the Potential of AI in Drug Discovery: Current Status, Barriers and Future Opportunities, 2023. Available from: 〈https://cms.wellcome.org/sites/default/files/2023-06/unlocking-the-potential-of-AI-in-drug-discovery_report.pdf〉.
2. Substance Abuse and Mental Health Services Administration (SAMHSA), Key Substance Use and Mental Health Indicators in the United States: Results from the 2021 National Survey on Drug Use and Health (HHS Publication No. PEP22–07-01–005, NSDUH Series H-57). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, 2022 [cited 2023 October 20, 2023]. Available from: 〈https://www.samhsa.gov/data/report/2021-nsduh-annual-national-report〉.
3. American Pscyhiatric Association (APA), Diagnostic And Statistical Manual Of Mental Disorders, fifth edition, Text Revision (DSM-5-TR). Arlington, VA, 2022.
4. Center for Disease Control and Prevention (CDC), National Vital Statistics System. Provisional Drug Overdose Death Counts, 2023 [cited 2023 October 20, 2023]. Available from: 〈https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm〉.
5. Barriers to broader use of medications to treat opioid use disorder;Mancher,2019